Cfs Pharma And Opticals Profile
Key Indicators
- Authorised Capital ₹ 4.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 14 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 78.60%
- Profit Growth 61.09%
- Ebitda 117.47%
- Net Worth 22.25%
- Total Assets 49.44%
About Cfs Pharma And Opticals
Cfs Pharma And Opticals Private Limited (CPAOPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 23 September 2010 and has a history of 14 years and four months. Its registered office is in New Delhi, India.
The Company is engaged in the Consumer Goods Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mahipal Sachdev, Alka Sachdev, and Ajay Jassal serve as directors at the Company.
Company Details
- Location
New Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U52310DL2010PTC208650
- Company No.
208650
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Sep 2010
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Cfs Pharma And Opticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mahipal Sachdev  | Director | 23-Sep-2010 | Current |
| Alka Sachdev | Director | 23-Sep-2010 | Current |
| Ajay Jassal | Director | 03-Feb-2016 | Current |
Financial Performance of Cfs Pharma And Opticals.
Cfs Pharma And Opticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 78.6% increase. The company also saw a substantial improvement in profitability, with a 61.09% increase in profit. The company's net worth Soared by an impressive increase of 22.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cfs Pharma And Opticals?
In 2021, Cfs Pharma And Opticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Irx Pharmaceuticals Private LimitedMahipal Sachdev is a mutual person
Ndcfs FoundationMahipal Sachdev and Alka Sachdev are mutual person
Vishwanethra Health Services Private LimitedMahipal Sachdev and Alka Sachdev are mutual person
Challa Eye Care Private LimitedMahipal Sachdev and Alka Sachdev are mutual person
Dr. Khunger Eye Care And Research Centre Private LimitedMahipal Sachdev and Alka Sachdev are mutual person
- New Delhi Centre For Sight Limited
Mahipal Sachdev and Alka Sachdev are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cfs Pharma And Opticals?
Cfs Pharma And Opticals has a workforce of 225 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cfs Pharma And Opticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cfs Pharma And Opticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
